384 related articles for article (PubMed ID: 12952274)
1. Inflammation in pulmonary arterial hypertension.
Dorfmüller P; Perros F; Balabanian K; Humbert M
Eur Respir J; 2003 Aug; 22(2):358-63. PubMed ID: 12952274
[TBL] [Abstract][Full Text] [Related]
2. The role of inflammation and autoimmunity in the pathophysiology of pulmonary arterial hypertension.
Kherbeck N; Tamby MC; Bussone G; Dib H; Perros F; Humbert M; Mouthon L
Clin Rev Allergy Immunol; 2013 Feb; 44(1):31-8. PubMed ID: 21394427
[TBL] [Abstract][Full Text] [Related]
3. [Pulmonary arterial hypertension in connective tissue disease].
Cottin V
Rev Mal Respir; 2006 Sep; 23(4 Suppl):13S61-72. PubMed ID: 17057632
[TBL] [Abstract][Full Text] [Related]
4. POEMS syndrome-related pulmonary hypertension is steroid-responsive.
Jouve P; Humbert M; Chauveheid MP; Jaïs X; Papo T
Respir Med; 2007 Feb; 101(2):353-5. PubMed ID: 16774822
[TBL] [Abstract][Full Text] [Related]
5. Chronic hypoxia aggravates monocrotaline-induced pulmonary arterial hypertension: a rodent relevant model to the human severe form of the disease.
Coste F; Guibert C; Magat J; Abell E; Vaillant F; Dubois M; Courtois A; Diolez P; Quesson B; Marthan R; Savineau JP; Muller B; Freund-Michel V
Respir Res; 2017 Mar; 18(1):47. PubMed ID: 28288643
[TBL] [Abstract][Full Text] [Related]
6. Reversible pulmonary hypertension in POEMS syndrome--another etiology of triggered pulmonary vasculopathy?
Paciocco G; Bossone E; Erba H; Rubenfire M
Can J Cardiol; 2000 Aug; 16(8):1007-12. PubMed ID: 10978936
[TBL] [Abstract][Full Text] [Related]
7. [Novel immunopathological approaches to pulmonary arterial hypertension].
Perros F; Montani D; Dorfmüller P; Huertas A; Chaumais MC; Cohen-Kaminsky S; Humbert M
Presse Med; 2011 Apr; 40 Suppl 1():1S3-13. PubMed ID: 21536178
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies in patients with primary pulmonary hypertension: association with anti-Ku.
Isern RA; Yaneva M; Weiner E; Parke A; Rothfield N; Dantzker D; Rich S; Arnett FC
Am J Med; 1992 Sep; 93(3):307-12. PubMed ID: 1524083
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary hypertension in POEMS syndrome: a new feature mediated by cytokines.
Lesprit P; Godeau B; Authier FJ; Soubrier M; Zuber M; Larroche C; Viard JP; Wechsler B; Gherardi R
Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):907-11. PubMed ID: 9517610
[TBL] [Abstract][Full Text] [Related]
10. Chemokine RANTES in severe pulmonary arterial hypertension.
Dorfmüller P; Zarka V; Durand-Gasselin I; Monti G; Balabanian K; Garcia G; Capron F; Coulomb-Lherminé A; Marfaing-Koka A; Simonneau G; Emilie D; Humbert M
Am J Respir Crit Care Med; 2002 Feb; 165(4):534-9. PubMed ID: 11850348
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary hypertension associated with POEMS syndrome.
Ribadeau-Dumas S; Tillie-Leblond I; Rose C; Saulnier F; Wemeau JL; Hatron PY; Wallaert B
Eur Respir J; 1996 Aug; 9(8):1760-2. PubMed ID: 8866608
[TBL] [Abstract][Full Text] [Related]
12. Monocrotaline-induced pulmonary arterial hypertension is attenuated by TNF-α antagonists via the suppression of TNF-α expression and NF-κB pathway in rats.
Wang Q; Zuo XR; Wang YY; Xie WP; Wang H; Zhang M
Vascul Pharmacol; 2013 Jan; 58(1-2):71-7. PubMed ID: 22846229
[TBL] [Abstract][Full Text] [Related]
13. CX(3)C chemokine fractalkine in pulmonary arterial hypertension.
Balabanian K; Foussat A; Dorfmüller P; Durand-Gasselin I; Capel F; Bouchet-Delbos L; Portier A; Marfaing-Koka A; Krzysiek R; Rimaniol AC; Simonneau G; Emilie D; Humbert M
Am J Respir Crit Care Med; 2002 May; 165(10):1419-25. PubMed ID: 12016106
[TBL] [Abstract][Full Text] [Related]
14. Primary pulmonary hypertension: immunogenetic response to high-mobility group (HMG) proteins and histone.
Morse JH; Barst RJ; Fotino M; Zhang Y; Flaster E; Fritzler MJ
Clin Exp Immunol; 1996 Nov; 106(2):389-95. PubMed ID: 8918589
[TBL] [Abstract][Full Text] [Related]
15. Evidence for the association of unexplained pulmonary hypertension in children with the major histocompatibility complex.
Barst RJ; Flaster ER; Menon A; Fotino M; Morse JH
Circulation; 1992 Jan; 85(1):249-58. PubMed ID: 1728456
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory mechanisms in the pathogenesis of pulmonary arterial hypertension.
El Chami H; Hassoun PM
Compr Physiol; 2011 Oct; 1(4):1929-41. PubMed ID: 23733693
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary hypertension in connective tissue diseases: an update.
Aithala R; Alex AG; Danda D
Int J Rheum Dis; 2017 Jan; 20(1):5-24. PubMed ID: 28205373
[TBL] [Abstract][Full Text] [Related]
18. POEMS syndrome in systemic lupus erythematosus.
Murphy N; Schumacher HR
J Rheumatol; 1992 May; 19(5):796-9. PubMed ID: 1613712
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic Benefits of Induced Pluripotent Stem Cells in Monocrotaline-Induced Pulmonary Arterial Hypertension.
Huang WC; Ke MW; Cheng CC; Chiou SH; Wann SR; Shu CW; Chiou KR; Tseng CJ; Pan HW; Mar GY; Liu CP
PLoS One; 2016; 11(2):e0142476. PubMed ID: 26840075
[TBL] [Abstract][Full Text] [Related]
20. Autoimmune aspects of primary pulmonary hypertension.
Yanai-Landau H; Amital H; Bar-Dayan Y; Levy Y; Gur H; Lin HC; Alosachie IJ; Peter JB; Shoenfeld Y
Pathobiology; 1995; 63(2):71-5. PubMed ID: 8554702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
